Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity

Overview of attention for article published in Frontiers in immunology, February 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 1 X post from an account with 9,417 followers.

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity https://t.co/VTxjtYAkc8

11 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.